Literature DB >> 19414422

Radioprotection.

Joel S Greenberger1.   

Abstract

Over 40% of cancer patients will require radiation therapy during management of their disease. Although radiation therapy improves the survival of a significant number of cancer patients, both acute radiation toxicity (which manifests during a course of clinical radiotherapy or shortly thereafter), and late toxicity (developing months to years after completion of radiotherapy) compromise overall outcomes for successfully treated cancer patients.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19414422      PMCID： PMC2981866     

Source DB:  PubMed          Journal:  In Vivo        ISSN： 0258-851X            Impact factor:   2.155


  108 in total

Review 1.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

Review 2.  The "pro-apoptotic genies" get out of mitochondria: oxidative lipidomics and redox activity of cytochrome c/cardiolipin complexes.

Authors:  V E Kagan; Y Y Tyurina; H Bayir; C T Chu; A A Kapralov; I I Vlasova; N A Belikova; V A Tyurin; A Amoscato; M Epperly; J Greenberger; S Dekosky; A A Shvedova; J Jiang
Journal:  Chem Biol Interact       Date:  2006-05-12       Impact factor: 5.192

Review 3.  Radiation protection in vivo by prostaglandins and related compounds of the arachidonic acid cascade.

Authors:  W R Hanson; K A Houseman; P W Collins
Journal:  Pharmacol Ther       Date:  1988       Impact factor: 12.310

Review 4.  Role of superoxide dismutase in cancer: a review.

Authors:  L W Oberley; G R Buettner
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

5.  Transplantation of vascular endothelial cells mediates the hematopoietic recovery and survival of lethally irradiated mice.

Authors:  John P Chute; Garrett G Muramoto; Alice B Salter; Sarah K Meadows; Dennis W Rickman; Benny Chen; Heather A Himburg; Nelson J Chao
Journal:  Blood       Date:  2006-11-09       Impact factor: 22.113

6.  Non-homologous end-joining defect in fanconi anemia hematopoietic cells exposed to ionizing radiation.

Authors:  José A Casado; María I Núñez; José C Segovia; José M Ruiz de Almodóvar; Juan A Bueren
Journal:  Radiat Res       Date:  2005-11       Impact factor: 2.841

7.  Interleukin 1 is a radioprotector.

Authors:  R Neta; S Douches; J J Oppenheim
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

Review 8.  Radioprotective gene therapy.

Authors:  J S Greenberger; M W Epperly; J Gretton; M Jefferson; S Nie; M Bernarding; V Kagan; H L Guo
Journal:  Curr Gene Ther       Date:  2003-06       Impact factor: 4.391

Review 9.  Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists.

Authors:  J E Moulder; B L Fish; E P Cohen
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

10.  Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer.

Authors:  W A Brock; S L Tucker; F B Geara; I Turesson; J Wike; J Nyman; L J Peters
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-07-30       Impact factor: 7.038
View more
  45 in total

1.  Dentofacial parameters explaining variability in retroclination of the maxillary central incisors.

Authors:  Bernd G Lapatki; Andreas Klatt; Jürgen Schulte-Mönting; Irmtrud E Jonas
Journal:  J Orofac Orthop       Date:  2007-03       Impact factor: 1.938

2.  The zebrafish--Danio rerio--is a useful model for measuring the effects of small-molecule mitigators of late effects of ionizing irradiation.

Authors:  Michael W Epperly; Nathan Bahary; Mubina Quader; Valerie Dewald; Joel S Greenberger
Journal:  In Vivo       Date:  2012 Nov-Dec       Impact factor: 2.155

Review 3.  Radioprotection of normal tissue cells.

Authors:  Patrick Maier; Frederik Wenz; Carsten Herskind
Journal:  Strahlenther Onkol       Date:  2014-03-18       Impact factor: 3.621

4.  Bactericidal/permeability-increasing protein (rBPI21) and fluoroquinolone mitigate radiation-induced bone marrow aplasia and death.

Authors:  Eva C Guinan; Christine M Barbon; Leslie A Kalish; Kalindi Parmar; Jeff Kutok; Christy J Mancuso; Liat Stoler-Barak; Eugénie E Suter; Janice D Russell; Christine D Palmer; Leighanne C Gallington; Annie Voskertchian; Jo-Anne Vergilio; Geoffrey Cole; Kaya Zhu; Alan D'Andrea; Robert Soiffer; Jerrold P Weiss; Ofer Levy
Journal:  Sci Transl Med       Date:  2011-11-23       Impact factor: 17.956

5.  Protective effect of an antithyroid compound against γ-radiation-induced damage in human colon cancer cells.

Authors:  Marina Perona; Maria A Dagrosa; Romina Pagotto; Mariana Casal; Omar Pignataro; Mario A Pisarev; Guillermo J Juvenal
Journal:  Radiat Environ Biophys       Date:  2014-05-09       Impact factor: 1.925

6.  Synthetic protection short interfering RNA screen reveals glyburide as a novel radioprotector.

Authors:  Jianfei Jiang; Peter R McDonald; Tracy M Dixon; Darcy Franicola; Xichen Zhang; Suhua Nie; Laura D Epperly; Zhentai Huang; Valerian E Kagan; John S Lazo; Michael W Epperly; Joel S Greenberger
Journal:  Radiat Res       Date:  2009-10       Impact factor: 2.841

7.  New paradigms and future challenges in radiation oncology: an update of biological targets and technology.

Authors:  Stanley L Liauw; Philip P Connell; Ralph R Weichselbaum
Journal:  Sci Transl Med       Date:  2013-02-20       Impact factor: 17.956

8.  Mitochondria-related gene expression changes are associated with fatigue in patients with nonmetastatic prostate cancer receiving external beam radiation therapy.

Authors:  Chao-Pin Hsiao; Dan Wang; Aradhana Kaushal; Leorey Saligan
Journal:  Cancer Nurs       Date:  2013 May-Jun       Impact factor: 2.592

9.  High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones.

Authors:  Kwanghee Kim; Julianne M Pollard; Andrew J Norris; J Tyson McDonald; Yingli Sun; Ewa Micewicz; Kelly Pettijohn; Robert Damoiseaux; Keisuke S Iwamoto; James W Sayre; Brendan D Price; Richard A Gatti; William H McBride
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

10.  Early and late administration of MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage.

Authors:  Benjamin Gauter-Fleckenstein; Katharina Fleckenstein; Kouros Owzar; Chen Jiang; Júlio S Rebouças; Ines Batinic-Haberle; Zeljko Vujaskovic
Journal:  Free Radic Biol Med       Date:  2010-01-20       Impact factor: 7.376
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.